findmyKOL
Clinical trialNCT06181552UnknownObservational

Development of CV Risk Prediction Tools Based on AI and Fundus Imaging Technology Study (PERFECT)

SponsorChina National Center for Cardiovascular DiseasesEnrollment1,072Cardiovascular Diseases
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jing Li, PhD, MD

    National Center for Cardiovascular Diseases, Fuwai Hospital

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Dec 2023
Primary completion
31 Mar 2025
Completion
30 Jun 2025
Last update posted
26 Dec 2023
Registered enrollment
1,072
Registry id
NCT06181552

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.